ORMDL3 rs8067532: Understanding Your Asthma Risk Variant
The rs8067532 polymorphism is a well-studied single nucleotide variant located in the 17q21 chromosomal region near the ORMDL3 gene. Extensively analyzed in childhood-onset asthma studies, this variant acts as an expression quantitative trait locus influencing cellular levels of ORMDL3 and neighboring genes. While carrying specific alleles has been linked to altered respiratory risk, it represents a modest statistical factor rather than a definitive diagnostic test.
What each genotype means
Baseline asthma risk
This genotype represents the baseline state for this variant in the ORMDL3 region. Research indicates that individuals with this genotype do not carry the specific risk-associated allele linked to increased ORMDL3 expression and childhood-onset asthma susceptibility. This is a common genetic profile observed in many populations.
This genotype is common, appearing in roughly 25% to 35% of individuals of European ancestry.
Increased asthma risk
Carrying one copy of the risk-associated allele is statistically linked to higher expression levels of the ORMDL3 gene. Studies suggest this genetic profile is associated with a moderately increased risk of developing childhood-onset asthma. This association is complex and may be influenced by environmental factors, such as early-life exposure to tobacco smoke.
This heterozygous genotype is found in approximately 40% to 50% of individuals of European ancestry.
Elevated asthma risk
Carrying two copies of the risk-associated allele is associated with the highest observed expression levels of ORMDL3 in this context. Research consistently links this genotype to an increased susceptibility to childhood-onset asthma compared to those without the risk alleles. Please note that genetic risk is only one factor in asthma development, and you should discuss any respiratory concerns with your healthcare provider.
This genotype is carried by roughly 15% to 25% of individuals of European ancestry.
Genetic Overview and the 17q21 Locus
The single nucleotide polymorphism rs8067532 is situated on chromosome 17 at band q21, a genomic region that came to prominence following landmark genome-wide association studies evaluating childhood asthma. In standard genomic references, the variant involves a single base transition between cytosine (C) and thymine (T). Rather than altering the amino acid sequence of a protein, rs8067532 resides in non-coding regulatory sequence, functioning as a cis-regulatory expression quantitative trait locus. This locus exhibits high linkage disequilibrium with multiple neighboring markers across the 17q21 core region, which spans several closely clustered genes including ORMDL3, GSDMB, and ZPBP2. Because these variations are frequently inherited together, determining which individual nucleotide directly drives biological effects has required extensive functional dissection.
Biological Role of the ORMDL3 Gene
The ORMDL3 gene encodes ORM1-like protein 3, a member of an evolutionarily conserved family of transmembrane proteins anchored in the membrane of the endoplasmic reticulum. ORMDL3 acts as a key homeostatic regulator of de novo sphingolipid synthesis by modulating the enzymatic activity of serine palmitoyltransferase. Beyond sphingolipid balance, ORMDL3 plays established roles in endoplasmic reticulum stress, unfolded protein response signaling, cellular autophagy, and intracellular calcium mobilization. When cellular ORMDL3 levels are elevated, bronchial epithelial cells and airway smooth muscle cells exhibit increased inflammatory responses, chemokine secretion, and structural remodeling tendencies. Changes in ORMDL3 expression have also been implicated in broader immune and inflammatory processes across multiple tissues.
Evidence on Asthma Susceptibility and Modifying Factors
Multiple large-scale genetic investigations, beginning with pivotal childhood asthma association studies and reinforced by replication cohorts in diverse ethnic backgrounds, demonstrate that 17q21 variants correlate with asthma risk. Studies evaluate rs8067532 alongside linked variants, noting increased susceptibility specifically for early-onset or childhood asthma rather than late-onset adult disease. However, the evidence strength for rs8067532 acting as an isolated clinical predictor is categorized as limited because individual effect sizes are modest, yielding odds ratios typically between 1.15 and 1.35. Furthermore, gene-environment interactions substantially modulate this predisposition. For instance, cohort analyses such as the EGEA study show that the elevated risk associated with homozygous 17q21 risk alleles is pronounced primarily when children are exposed to early-life environmental tobacco smoke or frequent viral respiratory infections.
Population Patterns and Global Distribution
The rs8067532 single nucleotide polymorphism is a common variation found at high frequencies throughout global populations. In individuals of European ancestry, the minor allele frequency typically spans between 0.40 and 0.50, meaning that heterozygous carriers and homozygous individuals represent significant fractions of the general population. In East Asian, African, and Hispanic/Latino cohorts, allele frequencies can vary, yet the variant and its corresponding linkage disequilibrium block remain widely distributed. Because the risk-associated allele is present in hundreds of millions of healthy individuals who never develop respiratory disease, carriage of this variant cannot be interpreted as an absolute risk factor, underscoring the polygenic and environmental architecture of complex immune conditions.
Clinical Interpretation and Everyday Actionability
Finding rs8067532 in personal genetic data should not be mistaken for a medical diagnosis of asthma or a guarantee that a person will develop breathing problems. Asthma is a complex, multifactorial trait influenced by hundreds of genetic loci together with environmental factors such as allergen exposure, air quality, viral illnesses, and second-hand smoke. Knowing one's genotype cannot guide clinical drug selection, alter prescription dosing, or predict how an individual responds to inhaled corticosteroids or bronchodilators. Individuals with persistent respiratory symptoms, wheezing, or a family history of atopic conditions should consult a healthcare provider for comprehensive pulmonary evaluation rather than relying on direct-to-consumer genetic markers.
How common is this variant?
The rs8067532 variant is common worldwide, exhibiting a minor allele frequency between 0.40 and 0.50 across European populations, with comparable common frequencies identified in diverse continental ancestral groups.
Frequently asked questions
Does having the rs8067532 risk genotype mean I will develop asthma?
No. The rs8067532 variant confers a modest statistical change in risk, not a certainty. Asthma is a complex trait caused by many genetic and environmental factors working together, and many people with the risk-associated genotype never experience respiratory illness.
Can this genetic test show if my child will outgrow their wheezing?
No, current clinical guidelines do not use rs8067532 or 17q21 genetic testing to forecast disease progression, remission, or severity. Clinical history, allergy evaluations, and pulmonary function testing remain the standard methods used by physicians to manage childhood respiratory symptoms.
Why is the 17q21 region so famous in asthma genetics?
The 17q21 locus was among the earliest and most consistently replicated chromosomal regions identified through childhood asthma genome-wide association studies. It contains a tight cluster of genes, including ORMDL3 and GSDMB, whose regulatory variants correlate with immune signaling and airway remodeling.
Does rs8067532 influence how someone responds to asthma inhalers?
There is currently no sufficient evidence indicating that rs8067532 alters responses to asthma controller medications or rescue inhalers. Any modifications to asthma treatment or medication dosing must be discussed directly with a qualified healthcare professional or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs8067532?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29